Global Radiation Oncology Market Report and Forecast 2024-2032

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Cancer Overview
    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Cancer Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Cancer Epidemiology (2016-2031)
    5.3    Europe Cancer Epidemiology (2016-2031)
    5.4    Asia-Pacific Cancer Epidemiology (2016-2031)
    5.5    Latin America Cancer Epidemiology (2016-2031)
    5.6    Middle East & Africa Cancer Epidemiology (2016-2031)
6    Global Radiation Oncology Market Overview 
    6.1    Global Radiation Oncology Market Historical Value (2017-2023) 
    6.2    Global Radiation Oncology Market Forecast Value (2024-2032)
7    Global Radiation Oncology Market Landscape
    7.1    Global Radiation Oncology Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Global Radiation Oncology Product Landscape
        7.2.1    Analysis by Type
        7.2.2    Analysis by Indications
        7.2.3    Analysis by End Users
8    Radiation Oncology Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Global Radiation Oncology Market Dynamics
    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model 
    10.4    Key Demand Indicators
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends 
    10.7    Value Chain Analysis
11    Global Radiation Oncology Market Segmentation 
    11.1    Global Radiation Oncology Market by Type
        11.1.1    Market Overview
        11.1.2    External Beam Radiation Therapy
            11.1.2.1    Linear Accelerators (Linac)
            11.1.2.2    Compact advanced radiotherapy systems
                11.1.2.2.1    Cyberknife
                11.1.2.2.2    Gamma Knife
                11.1.2.2.3    Tomotherapy
        11.1.3    Proton Therapy
            11.1.3.1    Cyclotron
            11.1.3.2    Synchrotron
        11.1.4    Internal Beam Radiation Therapy
            11.1.4.1    Brachytherapy
                11.1.4.1.1    Seeds
                11.1.4.1.2    Applicators and After loaders
                11.1.4.1.3    Electronic Brachytherapy
            11.1.4.2    Systemic Beam Radiation Therapy
            11.1.4.3    Others
    11.2    Global Radiation Oncology Market by Technology
        11.2.1    Market Overview
        11.2.2    External Beam Radiation Therapy
            11.2.2.1    Image-Guided Radiotherapy (IGRT)
            11.2.2.2    Intensity Modulated Radiotherapy (IMRT)
            11.2.2.3    Stereotactic Technology
            11.2.2.4    Proton Beam Therapy
            11.2.2.5    3D Conformal Radiotherapy (3D CRT)
            11.2.2.6    Volumetric Modulated Arc Therapy (VMAT)
        11.2.3    Brachytherapy
            11.2.3.1    Low-Dose Rate Brachytherapy
            11.2.3.2    High-Dose Rate Brachytherapy
    11.3    Global Radiation Oncology Market by Applications
        11.3.1    Market Overview
        11.3.2    External Beam Radiation Therapy
            11.3.2.1    Prostate Cancer
            11.3.2.2    Breast Cancer
            11.3.2.3    Lung Cancer
            11.3.2.4    Head and Neck Cancer
            11.3.2.5    Colorectal Cancer
            11.3.2.6    Others
        11.3.3    Internal Beam Radiation Therapy
            11.3.3.1    Prostate Cancer
            11.3.3.2    Gynecological Cancer
            11.3.3.3    Cervical Cancer
            11.3.3.4    Breast Cancer
            11.3.3.5    Penile Cancer
            11.3.3.6    Others
    11.4    Global Radiation Oncology Market by Region
        11.4.1    Market Overview
        11.4.2    North America 
        11.4.3    Europe
        11.4.4    Asia Pacific
        11.4.5    Latin America
        11.4.6    Middle East and Africa
12    North America Radiation Oncology Market
    12.1    Market Share by Country
    12.2    United States of America
    12.3    Canada
13    Europe Radiation Oncology Market
    13.1    Market Share by Country
    13.2    United Kingdom
    13.3    Germany
    13.4    France
    13.5    Italy
    13.6    Others
14    Asia Pacific Radiation Oncology Market
    14.1    Market Share by Country
    14.2    China
    14.3    Japan
    14.4    India
    14.5    ASEAN
    14.6    Australia
    14.7    Others
15    Latin America Radiation Oncology Market
    15.1    Market Share by Country
    15.2    Brazil
    15.3    Argentina
    15.4    Mexico
    15.5    Others
16    Middle East and Africa Radiation Oncology Market
    16.1    Market Share by Country
    16.2    Saudi Arabia
    16.3    United Arab Emirates
    16.4    Nigeria
    16.5    South Africa
    16.6    Others
17    Patent Analysis
    17.1    Analysis by Type of Patent
    17.2    Analysis by Publication year
    17.3    Analysis by Issuing Authority
    17.4    Analysis by Patent Age
    17.5    Analysis by CPC Analysis
    17.6    Analysis by Patent Valuation 
    17.7    Analysis by Key Players
18    Grants Analysis
    18.1    Analysis by year
    18.2    Analysis by Amount Awarded
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Grant Application
    18.5    Analysis by Funding Institute
    18.6    Analysis by NIH Departments
    18.7    Analysis by Recipient Organization 
19    Clinical Trials Analysis 
    19.1     Analysis by Trial Registration Year 
    19.2    Analysis by Trial Status 
    19.3    Analysis by Trial Phase 
    19.4    Analysis by Therapeutic Area 
    19.5    Analysis by Geography
20    Funding Analysis
    20.1    Analysis by Funding Instances
    20.2    Analysis by Type of Funding
    20.3    Analysis by Funding Amount
    20.4    Analysis by Leading Players
    20.5    Analysis by Leading Investors
    20.6    Analysis by Geography
21    Partnership and Collaborations Analysis
    21.1    Analysis by Partnership Instances
    21.2    Analysis by Type of Partnership
    21.3    Analysis by Leading Players
    21.4    Analysis by Geography
22    Regulatory Framework
    22.1    Regulatory Overview
        22.1.1    US FDA
        22.1.2    EU EMA
        22.1.3    INDIA CDSCO
        22.1.4    JAPAN PMDA
        22.1.5    Others
23    Supplier Landscape
    23.1    Accuray Incorporated
        23.1.1    Financial Analysis
        23.1.2    Product Portfolio
        23.1.3    Demographic Reach and Achievements
        23.1.4    Mergers and Acquisitions
        23.1.5    Certifications
    23.2    Elekta AB
        23.2.1    Financial Analysis
        23.2.2    Product Portfolio
        23.2.3    Demographic Reach and Achievements
        23.2.4    Mergers and Acquisitions
        23.2.5    Certifications
    23.3    Isoray Medical
        23.3.1    Financial Analysis
        23.3.2    Product Portfolio
        23.3.3    Demographic Reach and Achievements
        23.3.4    Mergers and Acquisitions
        23.3.5    Certifications
    23.4    Mevion Medical Systems
        23.4.1    Financial Analysis
        23.4.2    Product Portfolio
        23.4.3    Demographic Reach and Achievements
        23.4.4    Mergers and Acquisitions
        23.4.5    Certifications
    23.5    BD
        23.5.1    Financial Analysis
        23.5.2    Product Portfolio
        23.5.3    Demographic Reach and Achievements
        23.5.4    Mergers and Acquisitions
        23.5.5    Certifications
    23.6    ICAD,Inc.
        23.6.1    Financial Analysis
        23.6.2    Product Portfolio
        23.6.3    Demographic Reach and Achievements
        23.6.4    Mergers and Acquisitions
        23.6.5    Certifications
    23.7    Isoray, Inc
        23.7.1    Financial Analysis
        23.7.2    Product Portfolio
        23.7.3    Demographic Reach and Achievements
        23.7.4    Mergers and Acquisitions
        23.7.5    Certifications
    23.8    Optivus Proton Therapy, Inc.
        23.8.1    Financial Analysis
        23.8.2    Product Portfolio
        23.8.3    Demographic Reach and Achievements
        23.8.4    Mergers and Acquisitions
        23.8.5    Certifications
    23.9    P-Cure
        23.9.1    Financial Analysis
        23.9.2    Product Portfolio
        23.9.3    Demographic Reach and Achievements
        23.9.4    Mergers and Acquisitions
        23.9.5    Certifications
    23.10    Sensus Healthcare
        23.10.1    Financial Analysis
        23.10.2    Product Portfolio
        23.10.3    Demographic Reach and Achievements
        23.10.4    Mergers and Acquisitions
        23.10.5    Certifications
24    Global Radiation Oncology Market - Distribution Model (Additional Insight)
    24.1    Overview 
    24.2    Potential Distributors 
    24.3    Key Parameters for Distribution Partner Assessment 
25    Key Opinion Leaders (KOL) Insights (Additional Insight)
26    Company Competitiveness Analysis (Additional Insight)
    26.1    Very Small Companies
    26.2    Small Companies
    26.3    Mid-Sized Companies
    26.4    Large Companies
    26.5    Very Large Companies
27    Payment Methods (Additional Insight)
    27.1    Government Funded
    27.2    Private Insurance
    27.3    Out-of-Pocket

*Additional insights provided are customisable as per client requirements.